Business
Currency:USD
2023/FY
Stock NameRevenueRatio
Precision oncology testing514.25M91.19%
Development services and other49.7M8.81%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States526.52M93.36%
International37.42M6.64%